$PED
PEDEVCO CORP Stock $ped

$ped Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424003240 Filed on March 18, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$8.116M	$6.742M	$30.78M
YoY Change	-0.59%	13.79%	2.5%
Cost Of Revenue	$2.531M	$2.291M	$9.831M
YoY Change	2.64%	-1.29%	-5.44%
Gross Profit	$5.585M	$4.451M	$20.95M
YoY Change	-1.98%	23.5%	6.7%
Gross Profit Margin	68.81%	66.02%	68.06%
Selling, General & Admin	$1.495M	$1.890M	$6.008M
YoY Change	0.47%	8.25%	2.63%
% of Gross Profit	26.77%	42.46%	28.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.485M	$2.465M	$10.88M
YoY Change	35.03%	-47.84%	-2.49%
% of Gross Profit	62.4%	55.38%	51.9%
Operating Expenses	$7.511M	$4.354M	$26.71M
YoY Change	14.93%	-32.73%	-2.52%
Operating Profit	$617.0K	$97.00K	-$198.0K
YoY Change	-62.12%	-103.38%	-107.53%
Interest Expense	$149.0K	$150.0K	$422.0K
YoY Change	52.04%	94.81%
% of Operating Profit	24.15%	154.64%
Other Income/Expense, Net	$10.00K	$0.00	$10.00K
YoY Change	-92.48%	-100.0%	-95.33%
Pretax Income	$773.0K	-$4.021M	$264.0K
YoY Change	-56.13%	44.43%	-90.72%
Income Tax
% Of Pretax Income
Net Earnings	$773.0K	-$4.021M	$264.0K
YoY Change	-56.13%	44.43%	-90.72%
Net Earnings / Revenue	9.52%	-59.64%	0.86%
Basic Earnings Per Share	$0.01		$0.00
Diluted Earnings Per Share	$0.01	-$0.05	$0.00
COMMON SHARES
Basic Shares Outstanding	89.36M shares	87.25M shares	87.03M shares
Diluted Shares Outstanding	88.75M shares		87.03M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.29M	$18.52M	$18.52M
YoY Change	-5.98%	-37.09%	-37.09%
Cash & Equivalents	$13.29M	$20.72M
Short-Term Investments
Other Short-Term Assets	$196.0K	$260.0K	$260.0K
YoY Change	31.54%	4.42%	4.42%
Inventory
Prepaid Expenses
Receivables	$6.735M	$5.790M	$5.790M
Other Receivables	$106.0K	$42.00K	$42.00K
Total Short-Term Assets	$20.33M	$24.61M	$24.61M
YoY Change	1.27%	-23.36%	-23.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$94.42M	$91.91M	$91.91M
YoY Change	12.08%	14.57%	14.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.487M	$2.443M	$2.443M
YoY Change	-34.91%	-35.42%	-35.42%
Total Long-Term Assets	$97.96M	$95.45M	$95.45M
YoY Change	11.25%	13.63%	13.63%
TOTAL ASSETS
Total Short-Term Assets	$20.33M	$24.61M	$24.61M
Total Long-Term Assets	$97.96M	$95.45M	$95.45M
Total Assets	$118.3M	$120.1M	$120.1M
YoY Change	9.4%	3.4%	3.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.06M	$6.580M	$6.580M
YoY Change	227.56%	322.88%	322.88%
Accrued Expenses	$1.280M	$8.712M	$8.801M
YoY Change	-6.91%	-37.03%	-36.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.54M	$18.90M	$18.90M
YoY Change	129.61%	11.42%	11.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.743M	$2.393M	$2.393M
YoY Change	4.38%	-11.01%	-11.01%
Total Long-Term Liabilities	$2.743M	$2.393M	$2.393M
YoY Change	4.38%	-11.01%	-11.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.54M	$18.90M	$18.90M
Total Long-Term Liabilities	$2.743M	$2.393M	$2.393M
Total Liabilities	$18.28M	$21.29M	$21.29M
YoY Change	94.58%	8.35%	8.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$125.7M	-$126.5M
YoY Change	0.58%	-0.21%
Common Stock	$89.00K	$87.00K
YoY Change	2.3%	1.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$100.0M	$98.77M	$98.77M
YoY Change
Total Liabilities & Shareholders Equity	$118.3M	$120.1M	$120.1M
YoY Change	9.4%	3.4%	3.4%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$773.0K	-$4.021M	$264.0K
YoY Change	-56.13%	44.43%	-90.72%
Depreciation, Depletion And Amortization	$3.485M	$2.465M	$10.88M
YoY Change	35.03%	-47.84%	-2.49%
Cash From Operating Activities	-$4.295M	$12.05M	$23.48M
YoY Change	-341.02%	303.45%	46.93%
INVESTING ACTIVITIES
Capital Expenditures	$938.0K	$6.966M	$45.00K
YoY Change	-94.51%	730.27%	-99.63%
Acquisitions
YoY Change
Other Investing Activities	$12.00K	-$1.127M	-$747.0K
YoY Change		7950.0%	5235.71%
Cash From Investing Activities	-$926.0K	-$8.083M	-$35.74M
YoY Change	-94.58%	847.6%	191.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000	$0.00
YoY Change		-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-$4.295M	12.05M	$23.48M
Cash From Investing Activities	-$926.0K	-8.083M	-$35.74M
Cash From Financing Activities		0.000	$0.00
Net Change In Cash	-$5.221M	3.968M	-$12.26M
YoY Change	-65.86%	87.26%	-426.99%
FREE CASH FLOW
Cash From Operating Activities	-$4.295M	$12.05M	$23.48M
Capital Expenditures	$938.0K	$6.966M	$45.00K
Free Cash Flow	-$5.233M	$5.085M	$23.44M
YoY Change	-65.78%	136.73%	528.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001141197
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87250267	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85790267	shares
CY2022Q4	ped	Deferred Tax Assets Tax Deferred Expense Stock Options Nq DeferredTaxAssetsTaxDeferredExpenseStockOptionsNq	-174000	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35922
CY2023	dei	Entity Registrant Name EntityRegistrantName	PEDEVCO Corp.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-3755993
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	575 N. Dairy Ashford
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 210
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77079
CY2023	dei	City Area Code CityAreaCode	713
CY2023	dei	Local Phone Number LocalPhoneNumber	221-1768
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.001 Par Value Per Share
CY2023	dei	Trading Symbol TradingSymbol	PED
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	22883897	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	89355267	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023Q4	us-gaap	Cash Cash	18515000	usd
CY2022Q4	us-gaap	Cash Cash	29430000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	5790000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2430000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	42000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	260000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	249000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	24607000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	32109000	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	79186000	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	79372000	usd
CY2023Q4	us-gaap	Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost	12407000	usd
CY2022Q4	us-gaap	Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost	775000	usd
CY2023Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	91593000	usd
CY2022Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	80147000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1099000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	71000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2443000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3783000	usd
CY2023Q4	us-gaap	Assets Assets	120058000	usd
CY2022Q4	us-gaap	Assets Assets	116110000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6580000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1556000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8712000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13835000	usd
CY2023Q4	ped	Revenue Payable Current RevenuePayableCurrent	3371000	usd
CY2022Q4	ped	Revenue Payable Current RevenuePayableCurrent	1018000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	81000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	147000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	472000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18899000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16962000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	227000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2166000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2689000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	21292000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19651000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87250267	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85790267	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	87000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	86000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	225156000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	223114000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126477000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126741000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	98766000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	96459000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	120058000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116110000	usd
CY2023	us-gaap	Revenues Revenues	30784000	usd
CY2022	us-gaap	Revenues Revenues	30034000	usd
CY2023	us-gaap	Lease Cost LeaseCost	9831000	usd
CY2022	us-gaap	Lease Cost LeaseCost	10397000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6008000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5854000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10875000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11153000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	26714000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	27404000	usd
CY2023	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	-4268000	usd
CY2022	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	0	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-198000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2630000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	422000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	117000	usd
CY2023	us-gaap	Other Income OtherIncome	40000	usd
CY2022	us-gaap	Other Income OtherIncome	97000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	462000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	214000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	264000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2844000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87031692	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85513095	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87031692	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85513095	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2844000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10875000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11153000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2043000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2097000	usd
CY2023	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	-4268000	usd
CY2022	us-gaap	Gain Loss On Sale Of Oil And Gas Property GainLossOnSaleOfOilAndGasProperty	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	100000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	102000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3360000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	648000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	19000	usd
CY2022	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	0	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	11000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-77000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-159000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6979000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	435000	usd
CY2023	ped	Increase Decrease In Revenue Payable IncreaseDecreaseInRevenuePayable	2353000	usd
CY2022	ped	Increase Decrease In Revenue Payable IncreaseDecreaseInRevenuePayable	80000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23481000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15981000	usd
CY2023	ped	Payments To Acquire Drilling And Completion Costs PaymentsToAcquireDrillingAndCompletionCosts	34951000	usd
CY2022	ped	Payments To Acquire Drilling And Completion Costs PaymentsToAcquireDrillingAndCompletionCosts	12252000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	366000	usd
CY2022	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	0	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1122000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2023	ped	Cash Received Paid For Security Deposit CashReceivedPaidForSecurityDeposit	9000	usd
CY2022	ped	Cash Received Paid For Security Deposit CashReceivedPaidForSecurityDeposit	-14000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35743000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12266000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	35000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12262000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3750000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32977000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29227000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20715000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32977000	usd
CY2023	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	us-gaap	Interest Paid InterestPaid	0	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	ped	Accrued Oil And Gas Development Costs AccruedOilAndGasDevelopmentCosts	7674000	usd
CY2022	ped	Accrued Oil And Gas Development Costs AccruedOilAndGasDevelopmentCosts	10879000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	39000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	618000	usd
CY2023	ped	Proceeds From Issuance Of Restricted Common Stock ProceedsFromIssuanceOfRestrictedCommonStock	1000	usd
CY2022	ped	Proceeds From Issuance Of Restricted Common Stock ProceedsFromIssuanceOfRestrictedCommonStock	2000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	91483000	usd
CY2022	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2022	ped	Issuance Of Common Stock To Non Affiliate Amount IssuanceOfCommonStockToNonAffiliateAmount	35000	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2097000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2844000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	96459000	usd
CY2023	ped	Restricted Stock Issued During Period Value New Issues RestrictedStockIssuedDuringPeriodValueNewIssues	0	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2043000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	264000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	98766000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Use of Estimates in Financial Statement Preparation. </strong>The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as certain financial statement disclosures. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from these estimates. Significant estimates generally include those with respect to the amount of recoverable oil and gas reserves, the fair value of financial instruments, oil and gas depletion, asset retirement obligations, and stock-based compensation.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Concentrations of Credit Risk. </strong>Financial instruments which potentially subject the Company to concentrations of credit risk include cash deposits placed with financial institutions. The Company periodically assesses the financial condition of its financial institutions and considers any possible credit risk to be minimal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Sales to three customers comprised 42%, 35% and 18%, respectively, of the Company’s total oil and gas revenues for the year ended December 31, 2023 compared to sales to two customers comprising 63% and 20%, respectively, of the Company's total oil and gas revenues for the year ended December 31, 2022. The Company believes that, in the event that its primary customers are unable or unwilling to continue to purchase the Company’s production, there are a substantial number of alternative buyers for its production at comparable prices.</p>
CY2023Q4	us-gaap	Other Receivables OtherReceivables	3800000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1632334	shares
CY2023Q4	us-gaap	Cash Cash	18515000	usd
CY2022Q4	us-gaap	Cash Cash	29430000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	2200000	usd
CY2022Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	3547000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	20715000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	32977000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	1347000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30784000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30034000	usd
CY2022Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	176253000	usd
CY2023Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	185403000	usd
CY2022Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	775000	usd
CY2023Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	12407000	usd
CY2022Q4	ped	Asset Retirement Costs AssetRetirementCosts	1407000	usd
CY2023Q4	ped	Asset Retirement Costs AssetRetirementCosts	853000	usd
CY2022Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	98288000	usd
CY2023Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	107070000	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	80147000	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	91593000	usd
CY2021Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization	151338000	usd
CY2021Q4	ped	Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization	2559000	usd
CY2021Q4	ped	Asset Retirement Costs AssetRetirementCosts	789000	usd
CY2021Q4	us-gaap	Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment	88219000	usd
CY2021Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	66467000	usd
CY2022	ped	Capital Costs Incurred Recently Completed Wells CapitalCostsIncurredRecentlyCompletedWells	21573000	usd
CY2023	ped	Description Of Additional Paid DescriptionOfAdditionalPaid	The Company also acquired approximately 282 net mineral acres, and 6,465 net lease acres, in and around its existing footprint in the D-J Basin through multiple transactions with total acquisition and due diligence costs of $493,000 for the net mineral acres and $5,211,000 for the net lease acres
CY2023Q4	ped	Description Of Additional Paid DescriptionOfAdditionalPaid	estimated aggregate plugging and abandoning liabilities by over $3.2 million. The Company recognized a receivable of $56,000 due from Tilloo in post-closing adjustments, and as a result of the transaction, the Company recognized a $4.3 million loss on sale of oil and gas properties as reflected in the Statement of Operations for the year ended December 31, 2023
CY2023	ped	Capital Costs Incurred Recently Completed Wells CapitalCostsIncurredRecentlyCompletedWells	23131000	usd
CY2023	ped	Acquisition And Development Of Assets AcquisitionAndDevelopmentOfAssets	8400000	usd
CY2023	ped	Capital Cost Of Drilling And Completion CapitalCostOfDrillingAndCompletion	12500000	usd
CY2021Q3	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	500000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1200000	usd
CY2022Q4	us-gaap	Acquisition Costs Cumulative AcquisitionCostsCumulative	607000	usd
CY2022Q4	ped	Cost Of Due Deligence CostOfDueDeligence	688000	usd
CY2023	us-gaap	Depletion Depletion	10265000	usd
CY2022	us-gaap	Depletion Depletion	10069000	usd
CY2023Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.10	pure
CY2023Q4	ped	Note In Current Assets NoteInCurrentAssets	42000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	1099000	usd
CY2023Q4	ped	Accrued Interest AccruedInterest	16000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	3161000	usd
CY2023	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	587000	usd
CY2023	ped	Disposition Of Liabilities DispositionOfLiabilities	-971000	usd
CY2023	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	503000	usd
CY2023	ped	Changes In Estimates ChangesInEstimates	39000	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2313000	usd
CY2022Q4	ped	Cureent Asset Retirement CureentAssetRetirement	472000	usd
CY2023Q4	ped	Cureent Asset Retirement CureentAssetRetirement	147000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	10000	usd
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2027-02-28
CY2023	ped	Monthly Rent MonthlyRent	9200	usd
CY2023	ped	Security Deposit And Prepaid Rent SecurityDepositAndPrepaidRent	14700	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	105000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	89000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	227000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2023	ped	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P3Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0790	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	110000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	112000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	115000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	19000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	356000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	40000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2023	us-gaap	Other Commitments Description OtherCommitmentsDescription	In the D-J Basin Asset, no net acres expire during 2024 (net to our direct ownership interest only), with 1,721 and 4,108 net acres set to expire for the years ending December 31, 2025 and 2026 respectively, and 1,578 net acres thereafter, if we fail to meet drilling commitments or obtain term assignment extensions (net to our direct ownership interest only). In the Permian Basin Asset, 40, 0 and 0 net acres are set to expire for the years ending December 31, 2024, 2025, 2026, respectively, and 798 net acres thereafter
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1460000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1440000	shares
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	1621000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	1673000	usd
CY2023Q4	ped	Unamortized Stock Based Compensation Expense Restricted Stock Option UnamortizedStockBasedCompensationExpenseRestrictedStockOption	819000	usd
CY2022Q4	ped	Unamortized Stock Based Compensation Expense Restricted Stock Option UnamortizedStockBasedCompensationExpenseRestrictedStockOption	878000	usd
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	540000	shares
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.09
CY2023Q1	us-gaap	Contract Termination Claims Description ContractTerminationClaimsDescription	The options have a term of five years and fully vest in January 2026, with 33.3% vesting each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	429000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions	0.0361	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.13	pure
CY2022Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	520000	shares
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.17
CY2022Q1	us-gaap	Contract Termination Claims Description ContractTerminationClaimsDescription	The options have a term of five years and fully vest on January 2025, with 33.3% vesting each subsequent year from the date of grant, contingent upon the recipient’s continued service with the Company
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	454000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions	0.0156	pure
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.20	pure
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	422000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	424000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1407667	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.51
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1123435	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.80
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	540000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.09
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	520000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.17
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	315333	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.99
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	235768	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.17
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1632334	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.28
CY2023	ped	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a	P2Y9M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1407667	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.51
CY2022	ped	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a	P2Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	665667	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.45
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	575667	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.79
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y7M6D
CY2023	us-gaap	Net Income Loss NetIncomeLoss	264000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2844000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87031692	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85513095	shares
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2022	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87031692	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85513095	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1632334	shares
CY2022	ped	Share Equivalents Related To Options To Purchase Of Commmon Stock ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock	1407667	shares
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0664	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0664	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.0000	pure
CY2023	ped	Meals And Entertainment MealsAndEntertainment	0.0048	pure
CY2022	ped	Meals And Entertainment MealsAndEntertainment	0.0002	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance	0.2399	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance	0.0249	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.5211	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.3015	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2023Q4	ped	Deferred Tax Assets Tax Deferred Expense Accretion DeferredTaxAssetsTaxDeferredExpenseAccretion	588000	usd
CY2022Q4	ped	Deferred Tax Assets Tax Deferred Expense Accretion DeferredTaxAssetsTaxDeferredExpenseAccretion	425000	usd
CY2023Q4	ped	Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties	-2844000	usd
CY2022Q4	ped	Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties	1516000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	1000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	1000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	5343000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses	5343000	usd
CY2023Q4	ped	Deferred Tax Assets Tax Deferred Expense Lease Deferred Tax Liability DeferredTaxAssetsTaxDeferredExpenseLeaseDeferredTaxLiability	87000	usd
CY2022Q4	ped	Deferred Tax Assets Tax Deferred Expense Lease Deferred Tax Liability DeferredTaxAssetsTaxDeferredExpenseLeaseDeferredTaxLiability	-58000	usd
CY2023Q4	ped	Deferred Tax Assets Tax Deferred Expense Rou Assets DeferredTaxAssetsTaxDeferredExpenseRouAssets	-87000	usd
CY2022Q4	ped	Deferred Tax Assets Tax Deferred Expense Rou Assets DeferredTaxAssetsTaxDeferredExpenseRouAssets	80000	usd
CY2023Q4	ped	Deferred Tax Assets Tax Deferred Expense Gain Loss From Sale Of Fa And Or Og Properties DeferredTaxAssetsTaxDeferredExpenseGainLossFromSaleOfFaAndOrOGProperties	167000	usd
CY2022Q4	ped	Deferred Tax Assets Tax Deferred Expense Gain Loss From Sale Of Fa And Or Og Properties DeferredTaxAssetsTaxDeferredExpenseGainLossFromSaleOfFaAndOrOGProperties	-59000	usd
CY2022Q4	ped	Deferred Tax Assets Tax Deferred Expense Loss On Aro DeferredTaxAssetsTaxDeferredExpenseLossOnAro	23000	usd
CY2023Q4	ped	Deferred Tax Assets Tax Deferred Expense Loss On Aro DeferredTaxAssetsTaxDeferredExpenseLossOnAro	23000	usd
CY2023Q4	ped	Deferred Tax Assets Tax Deferred Expense Stock Options Nq DeferredTaxAssetsTaxDeferredExpenseStockOptionsNq	-174000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1356000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1507000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	26863000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	24080000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4304000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3423000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35801000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-305000	usd
CY2023	ped	Finite Lived Intangible Assets Remaining Amortization Period FiniteLivedIntangibleAssetsRemainingAmortizationPeriod	P15Y
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	128000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	93000000	usd
CY2023	ped	Not Utilized Amount Expiry NotUtilizedAmountExpiry	35000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	36106000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35801000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36106000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023	ped	Taxable Income Percent TaxableIncomePercent	0.80	pure

Files In Submission

Name	View Source	Status
0001654954-24-003240-index-headers.html	Edgar Link	pending
0001654954-24-003240-index.html	Edgar Link	pending
0001654954-24-003240.txt	Edgar Link	pending
0001654954-24-003240-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ped-20231231.xsd	Edgar Link	pending
ped_10k.htm	Edgar Link	pending
ped_10kimg1.jpg	Edgar Link	pending
ped_10kimg6.jpg	Edgar Link	pending
ped_10kimg7.jpg	Edgar Link	pending
ped_10kimg8.jpg	Edgar Link	pending
ped_10kimg9.jpg	Edgar Link	pending
ped_ex211.htm	Edgar Link	pending
ped_ex231.htm	Edgar Link	pending
ped_ex232.htm	Edgar Link	pending
ped_ex232img2.jpg	Edgar Link	pending
ped_ex311.htm	Edgar Link	pending
ped_ex312.htm	Edgar Link	pending
ped_ex321.htm	Edgar Link	pending
ped_ex322.htm	Edgar Link	pending
ped_ex991.htm	Edgar Link	pending
ped_ex991img1.jpg	Edgar Link	pending
ped_ex991img2.jpg	Edgar Link	pending
ped_ex991img3.jpg	Edgar Link	pending
ped_ex991img4.jpg	Edgar Link	pending
ped_ex991img5.jpg	Edgar Link	pending
ped_ex991img6.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
ped-20231231_def.xml	Edgar Link	unprocessable
ped-20231231_lab.xml	Edgar Link	unprocessable
ped_10k_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ped-20231231_cal.xml	Edgar Link	unprocessable
ped-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PED
PEDEVCO CORP Stock $ped

2024 Q1 Form 10-K Financial Statement

#000165495424003240 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED PEDEVCO CORP Stock $ped

2024 Q1 Form 10-K Financial Statement

#000165495424003240 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PED
PEDEVCO CORP Stock $ped